A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group

The Journal of Infectious Diseases
J E FeinbergM A Jacobson

Abstract

Cytomegalovirus (CMV) disease is a common complication of advanced human immunodeficiency virus (HIV) infection. Administration of oral valaciclovir, a valine ester of acyclovir, achieves sufficient plasma acyclovir levels to inhibit many clinical isolates. Acyclovir has been associated with enhanced survival in AIDS but not with CMV disease prevention. CMV-seropositive patients (1227) with CD4 cell counts <100/mm3 were enrolled in a randomized, double-blind trial. Valaciclovir, 8 g/day, was compared with acyclovir, 3.2 or 0.8 g/day, for CMV prevention; all three arms were compared for survival. The confirmed CMV disease rate was 11.7% among valaciclovir recipients and 17.5% in the pooled acyclovir arms, a 33% reduction in risk. Time to confirmed CMV disease was significantly longer for the valaciclovir group (P = .03). A trend toward earlier mortality for valaciclovir recipients was seen (P = .06). Toxicity and earlier medication discontinuation were more common in this group. Valaciclovir significantly reduces the risk of CMV disease. Further exploration of a better-tolerated dose is warranted.

Citations

Sep 25, 2003·Journal of Cutaneous Medicine and Surgery·Jashin J WuStephen K Tyring
Jan 12, 1999·Disease-a-month : DM·H W HorowitzG P Wormser
Dec 2, 1998·Antiviral Research·M D de JongS A Spector
Sep 25, 2003·Journal of Clinical Epidemiology·Denise L JacobsonUNKNOWN Outcomes Committee of the Adult AIDS Clinical Trials Group
Nov 24, 1999·International Journal of Antimicrobial Agents·M Jouan, C Katlama
Apr 22, 1999·The New England Journal of Medicine·H H Balfour
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S CurrierUNKNOWN Adult Clinical Trial Group
Apr 21, 2005·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Constance A BensonUNKNOWN Infectious Diseases Society of America
Jan 6, 2001·Sexually Transmitted Infections·J R Deayton
Jul 2, 2002·Infectious Diseases in Obstetrics and Gynecology·UNKNOWN US Public Health Service, Infectious Diseases Society of America, Prevention of Opportunistic Infections Working Group
Jun 25, 2009·Seminars in Hematology·Timothy Jancel, Scott R Penzak
Mar 24, 2007·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Sook-Bin Woo, Stephen J Challacombe
May 11, 2006·HIV Clinical Trials·Edward MillsGordon H Guyatt
Dec 14, 2001·HIV Clinical Trials·UNKNOWN US Public Health Service (USPHS)UNKNOWN USPHS/IDSA Prevention of Opportunistic Infections Working Group
Jan 5, 2002·Expert Opinion on Pharmacotherapy·David A Baker
Jan 15, 2004·Obstetrics and Gynecology Clinics of North America·Deborah M Money
Nov 11, 2006·Journal of Intensive Care Medicine·Jennifer L Taylor, Scott M Palmer
Sep 16, 2010·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Rosa F YehJoseph C Gathe
Aug 11, 2018·Ocular Immunology and Inflammation·Souska ZandiJustus G Garweg
Oct 21, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Terri WarrenClare A Brennan
Nov 1, 2008·Journal of Clinical Apheresis·Mark E BrecherYara A Park
Dec 24, 2008·Reviews in Medical Virology·P D Griffiths
Oct 19, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Vicky BrocklebankDavid Kavanagh
Jan 11, 2001·Drugs·D T Leung, S L Sacks
Jun 3, 2009·Expert Review of Anti-infective Therapy·Sarah S WilsonBetsy C Herold
Apr 4, 2002·Blood·Per LjungmanUNKNOWN Valacyclovir International Bone Marrow Transplant Study Group
Aug 24, 1999·Journal of Acquired Immune Deficiency Syndromes : JAIDS·D JayasekaraJ G Gambertoglio
Jul 22, 2005·The Journal of General Virology·G M ScottW D Rawlinson
Sep 28, 2002·The Journal of Infectious Diseases·Paul D Griffiths
Sep 28, 2002·The Journal of Infectious Diseases·Per Ljungman
Mar 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Drew J WinstonUNKNOWN Valacyclovir Cytomegalovirus Study Group
Jan 12, 2001·AIDS·C J FichtenbaumUNKNOWN AIDS Clinical Trials Group New Works Concept Sheet Team 064
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeffrey I CohenUNKNOWN B Virus Working Group
Apr 30, 2009·Expert Review of Anti-infective Therapy·Antonio VolpiPasquale Sordillo
Oct 7, 2006·Current Opinion in Gastroenterology·G Meng, P D Smith
May 3, 2019·Investigative Ophthalmology & Visual Science·Gary N HollandUNKNOWN Studies of Ocular Complications of AIDS Research Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.